MedPath

Clomifene

Generic Name
Clomifene
Brand Names
Clomid
Drug Type
Small Molecule
Chemical Formula
C26H28ClNO
CAS Number
911-45-5
Unique Ingredient Identifier
1HRS458QU2
Background

A triphenyl ethylene stilbene derivative which is an estrogen agonist or antagonist depending on the target tissue.

Indication

Used mainly in female infertility due to anovulation (e.g. due to polycystic ovary syndrome) to induce ovulation.

Associated Conditions
Ovulatory Dysfunction

Hypogonadism in Young Men With Type 2 Diabetes

Phase 2
Terminated
Conditions
Hypogonadotropic Hypogonadism
Type 2 Diabetes
Interventions
First Posted Date
2010-07-01
Last Posted Date
2019-10-04
Lead Sponsor
State University of New York at Buffalo
Target Recruit Count
5
Registration Number
NCT01155518
Locations
🇺🇸

Millard Fillmore Gates Hospital, Buffalo, New York, United States

Assessment of Multiple Intrauterine Gestations From Ovarian Stimulation

Phase 3
Completed
Conditions
Pregnancy
Unexplained Infertility
Interventions
Drug: Follicle Stimulating Hormone (gonadotropin)
First Posted Date
2010-01-08
Last Posted Date
2015-02-02
Lead Sponsor
Yale University
Target Recruit Count
900
Registration Number
NCT01044862
Locations
🇺🇸

University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

🇺🇸

University of Colorado, Aurora, Colorado, United States

🇺🇸

University of Alabama Birmingham, Birmingham, Alabama, United States

and more 11 locations

Traditional Clomiphene Citrate Administration vs. Stair-step Approach

Phase 3
Completed
Conditions
Ovulatory Dysfunction
Anovulation
Ovulation Induction
Interventions
First Posted Date
2009-11-05
Last Posted Date
2018-01-08
Lead Sponsor
University of Oklahoma
Target Recruit Count
120
Registration Number
NCT01008319
Locations
🇺🇸

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

Short-term Structured Exercise Training Program Plus Diet Intervention in Patients With Polycystic Ovary Syndrome (PCOS)

Phase 4
Completed
Conditions
Polycystic Ovary Syndrome
Anovulation
Interventions
Other: SET-diet plus clomiphene
Behavioral: Structured exercise program plus hypocaloric diet
First Posted Date
2009-10-29
Last Posted Date
2010-11-03
Lead Sponsor
University Magna Graecia
Target Recruit Count
96
Registration Number
NCT01004068
Locations
🇮🇹

"Pugliese" Hospital, Catanzaro, Italy

Comparison of Micro-dose Human Chorionic Gonadotropin (hCG) With Human Menopausal Gonadotropin (HMG) in Polycystic Ovary Syndrome

Phase 1
Completed
Conditions
Endocrine System Diseases
Gonadal Disorders
Interventions
Drug: low dose human chorionic gonadotropin
First Posted Date
2009-07-28
Last Posted Date
2011-07-15
Lead Sponsor
Royan Institute
Target Recruit Count
10
Registration Number
NCT00947713
Locations
🇮🇷

Royan institute, Reproductive Medicine Research Centre, ACECR, Tehran, Iran, Islamic Republic of

Comparison of Clomiphene Citrate and Gonadotropins in Ovulation Induction Cycles

Phase 4
Completed
Conditions
Infertility
Interventions
Drug: gonadotropins
First Posted Date
2009-02-04
Last Posted Date
2012-03-28
Lead Sponsor
Universitair Ziekenhuis Brussel
Target Recruit Count
40
Registration Number
NCT00835744
Locations
🇧🇪

UZ Brussel, Jette, Belgium

Clomiphene Citrate (CC)/Gonadotropin/Gonadotropin Releasing Hormone (GnRH) Antagonist Versus Gonadotropin/GnRH Agonist

Phase 4
Completed
Conditions
Ovarian Stimulation
Interventions
Procedure: Ultrasound
Drug: rFSH
Drug: gonadotopin (HMG)
First Posted Date
2009-01-28
Last Posted Date
2009-01-28
Lead Sponsor
Yazd Research & Clinical Center for Infertility
Target Recruit Count
200
Registration Number
NCT00830492
Locations
🇮🇷

Yazd Research and Clinical Center For Infertility, Yazd, Iran, Islamic Republic of

Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH Delivered From a Iontophoretic Patch Compared to Oral Treatment With Clomiphene or Placebo in Infertile Females

Phase 2
Completed
Conditions
Infertility
Interventions
First Posted Date
2008-11-24
Last Posted Date
2015-09-09
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
350
Registration Number
NCT00796289
Locations
🇺🇸

Florida Fertility Institute, Clearwater, Florida, United States

🇺🇸

All Women's Healthcare of Wesy Broward, Inc., Plantation, Florida, United States

🇺🇸

A Woman's Center for Reproductive Medicine, Baton Rouge, Louisiana, United States

and more 32 locations

PCOSMIC Trial - PolyCystic Ovary Syndrome, Metformin for Infertility With Clomiphene

Phase 4
Completed
Conditions
Polycystic Ovary Syndrome
Interventions
First Posted Date
2008-11-21
Last Posted Date
2008-11-21
Lead Sponsor
University of Auckland, New Zealand
Target Recruit Count
171
Registration Number
NCT00795808
Locations
🇳🇿

University of Auckland, Auckland, New Zealand

Pregnancy in Polycystic Ovary Syndrome II

Phase 3
Completed
Conditions
Polycystic Ovary Syndrome
Pregnancy
Interventions
First Posted Date
2008-07-21
Last Posted Date
2018-06-14
Lead Sponsor
Yale University
Target Recruit Count
750
Registration Number
NCT00719186
Locations
🇺🇸

Pennsylvania State University College of Medicine, Hershey, Pennsylvania, United States

🇺🇸

University of Colorado, Aurora, Colorado, United States

🇺🇸

Yale University, New Haven, Connecticut, United States

and more 9 locations
© Copyright 2025. All Rights Reserved by MedPath